Elixinol Wellness Ltd · ASX:EXL

Elixinol Wellness — H1 FY2026 Earnings Presentation

23 slides from Elixinol Wellness's earnings presentation, Sep 7, 2026

  1. Slide 1: US Divestment Completion & Business Update

    ASX: EXL | HALF-YEAR ENDED 30 JUNE 2026 US Divestment Completion & For personal use only Business Update September 2026 Elixinol Wellness Limited ASX Code: EXL Building on a stabilised, higher-margin Australian nutrition and wellness platform Based on the Audited Interim financial statements for the

  2. Slide 2: Important Notice & Disclaimer

    Important Notice & Disclaimer The following material is for general information purposes only and should not be relied on for the making of any investment decision. Any investment in Elixinol Wellness Limited ACN 621 479 794 (Elixinol Wellness) is subject to a number of investment risks including th

  3. Slide 3: Key Messages

    Key Messages For personal use only 01 02 03 04 Transformational US Business Stabilisation of Positioned for H1 FY26 Results Divestment the Capital Base Growth Performance highlights Transaction rationale, Convertible note Section two: the and earnings drivers for terms and completion structure, proc

  4. Slide 4: H1 FY2026 Results

    H1 FY2026 RESULTS Materially improved half with increased margins and operational efficiency For personal use only GROUP REVENUE (CONTINUING OPS) GROSS MARGIN (CONTINUING OPS) ADJUSTED EBITDA LOSS H1 FY25 $6.8m → $7.2m H1 FY25 33.5% → 43.2% H1 FY25 $(2.1)m → $(0.1)m +5.8% +9.8 pts +94% STATUTORY LOS

  5. Slide 5: Earnings Quality

    EARNINGS QUALITY Adjusted EBITDA improvement of +$2.0M on the prior half For personal use only H1 FY26 $'000 H1 FY25 $'000 WHAT DROVE THE IMPROVEMENT Loss after income tax (973) (2,941) • Gross profit increased $0.84 million to Add back: Finance costs 223 279 $3.11 million. Less: Interest income (4)

  6. Slide 6: Australia Segment Performance

    AUSTRALIA SEGMENT PERFORMANCE Australian brands drive revenue growth of +5.8% For personal use only Key Australian brand revenue by half ($M) Key Brands ($'000) H1 FY25 H1 FY26 Change 2.9 Hemp Foods Australia 2,516 2,871 +14.1% 2.5 The Healthy Chef 1,694 2,070 +22.2% 2.1 Hemp Ingredients 1,139 1,326

  7. Slide 7: Portfolio & Corporate Actions

    PORTFOLIO & CORPORATE ACTIONS Simplifying the portfolio, lowering costs For personal use only Non-core US business Small Parcel Sale Facility 1 sale 2 completed The Group to divest Elixinol LLC (US), held for sale / Established 20 April 2026 for sub-marketable discontinued at 30 June 2026 ($181k ass

  8. Slide 8: Balance Sheet

    BALANCE SHEET Balance sheet held broadly steady through the reshaping For personal use only Group ($'000) 30 Jun 2026 31 Dec 2025 Movement NET TANGIBLE ASSETS / SHARE* Cash and cash equivalents 996 1,405 (409) (0.54)c Total current assets 5,425 5,700 (275) vs (1.12)c at 30 Jun 2025 Total non-current

  9. Slide 9: Cash Flow

    CASH FLOW Underlying Operating1 cash flow turned positive Net cash flow by activity ($M) For personal use only CLOSING CASH (STATEMENT OF CASH FLOWS) 1.6 1.44 1.4 1.2 $1.0m 1.0 H1 FY25: $1.1m 0.8 0.6 0.4 +1.22 0.31 RECEIPTS FROM CUSTOMERS 0.2 0.07 0.01 0.0 -0.2 -0.03 $7.42m -0.4 H1 FY25: $7.95m -0.6

  10. Slide 10: US Divestment: Sharpening Our Australian Focus

    US Divestment: Sharpening Our Australian Focus For personal use only Sharper strategic focus Lower regulatory risk The natural owner Resources and management attention Removes uncertainty tied to the Ananda Health brings vertically concentrated on our Australian health evolving US regulatory framewo

  11. Slide 11: Convertible Note: A Stronger Capital Base

    Convertible Note: A Stronger Capital Base For personal use only A$1.06m 12% p.a. 31 Dec 2027 26 Aug 2026 Offer attracted 1,055,800 Fixed coupon, payable Maturity date, converting Notes issued and funds notes at A$1.00 face value annually to EXL ordinary shares received Why it matters Approved by sha

  12. Slide 12: Reset to Growth

    SECTION TWO • FUTURE AND GROWTH For personal use only Reset to Growth The platform, the market and the pipeline behind the next phase Phase 01 Phase 02 Phase 03 Reset Proof Growth FY25 – H1 FY26 H2 FY26 FY27 and beyond Costs rebased, portfolio simplified, Priceline rollout, Mt Elephant in Functional

  13. Slide 13: A Wellness Platform: Four Brands, Each With a Clear Purpose

    A Wellness Platform: Four Brands, Each With a Clear Purpose For personal use only The Healthy Chef Mt Elephant Hemp Foods Australia B2B Ingredients Women's strength, vitality Better-for-you indulgence and Plant-based nutrition and Nature-led innovation, private and healthy ageing family wellness ing

  14. Slide 14: Australia's Largest Hemp Foods Company

    Australia's Largest Hemp Foods Company For personal use only A vertically integrated platform connecting contracted supply, Australian processing and established retail relationships. 2 major grocery retailers supplied under contracted arrangements 2027 existing supply contracts extend to this date

  15. Slide 15: The Healthy Chef Is Emerging as a Core Growth Engine

    The Healthy Chef Is Emerging as a Core Growth Engine For personal use only A$2.07m +22.2% H1 FY26 revenue growth vs H1 FY25 29% +A$0.38m of Australian segment revenue revenue added year on year Premium ecommerce base Functional innovation Pharmacy scale Direct customer relationships and New formats

  16. Slide 16: Priceline Puts The Healthy Chef in Front of a National Audience

    Priceline Puts The Healthy Chef in Front of a National Audience For personal use only ~410 Priceline Pharmacy stores in the Stage 1 rollout Pharmacy distribution gives The Healthy Chef mass physical visibility alongside its premium ecommerce base — reaching new customers where health advice is alrea

  17. Slide 17: The Wellness Market Is Shifting Toward Healthy Ageing

    The Wellness Market Is Shifting Toward Healthy Ageing For personal use only US$6.8tn US$9.8tn Up to 60% global wellness economy in 2024 projected size by 2029 of consumers rank healthy ageing a top or very important priority Where EXL plays The opportunity sits where everyday nutrition meets strengt

  18. Slide 18: The Portfolio Already Has a Credible Entry Point

    The Portfolio Already Has a Credible Entry Point For personal use only 01 02 03 Protein waters Metabolic burn Nutritional peptides Lighter, convenient protein for everyday Everyday metabolic support Sleep, muscle and expanded weight use On shelf now management On shelf now Pipeline From now to next

  19. Slide 19: Growth Comes From Four Practical Engines

    Growth Comes From Four Practical Engines For personal use only 01 Product innovation 02 Channel expansion Build around protein, healthy ageing, convenience and Scale through ecommerce, grocery, pharmacy, health better-for-you indulgence. food and B2B. 03 Operating discipline 04 Selective acquisition

  20. Slide 20: The Next 6–12 Months Offer Multiple Proof Points

    The Next 6–12 Months Offer Multiple Proof Points For personal use only Retail Priceline rollout and broader pharmacy awareness Grocery Mt Elephant national expansion and new formats Innovation Functional nutrition and nutritional peptide pipeline Portfolio Continued mix improvement and B2B opportuni

  21. Slide 21: Re-Rating Upside as Growth Is Priced In

    Re-Rating Upside as Growth Is Priced In For personal use only EXL's current valuation provides a low starting point as the Group moves from reset to growth. A$3.5m A$14.4m A$5.9m 0.24× L12M revenue L12M gross profit market cap / revenue market capitalisation A$0.008 per share on 438.2m shares, at 04

  22. Slide 22: A stronger foundation. A clearer position. A growing pipeline.

    ELIXINOL WELLNESS | ASX: EXL For personal use only A stronger foundation. A clearer position. A growing pipeline. We are building a scalable wellness platform in categories supported by long-term consumer demand. LIVE WELL LIVE STRONG AGE BETTER investorhub.elixinolwellness.com

  23. Slide 23: Elixinol Wellness Limited

    For personal use only Elixinol Wellness Limited For further information: Natalie Butler, CEO & Executive Director natalie.butler@elixinolwellness.com ASX code: EXL | www.elixinolwellness.com https://investorhub.elixinolwellness.com/link/ej6Zxe This presentation has been prepared from the Audited Int

Elixinol Wellness — H1 FY2026 Earnings Presentation on 6ix